NCT07185334

Brief Summary

This study aims to evaluate the efficacy of using a polyester mesh endoprosthesis with a fluoropolymer coating in reducing postoperative complications, particularly protrusions, following subcutaneous mastectomy with simultaneous prepectoral placement of textured breast implants in women with breast cancer

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable breast-cancer

Timeline
12mo left

Started May 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
May 2025May 2027

Study Start

First participant enrolled

May 15, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 2, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

September 22, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2027

Last Updated

September 22, 2025

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

September 2, 2025

Last Update Submit

September 17, 2025

Conditions

Keywords

Fluoropolymer coated meshImplant-based reconstruction in breast cancer patients

Outcome Measures

Primary Outcomes (1)

  • Frequency of protrusions throughout the year

    Implant protrusion is a complication that occurs after reconstructive plastic surgery. In this type of surgery, the implant is displaced from its anatomically correct position leading to its protrusion through the skin. This happens when the integrity or strength of the tissues that hold the implant (such as capsules, muscles, and fascia) is compromised.

    1 year

Secondary Outcomes (1)

  • 1. Frequency of seroma 2. Frequency of Rippling 3. Frequency of Capsular contracture 4. Frequency of Dystopia

    1 year

Study Arms (2)

Main group

EXPERIMENTAL

The main group will consist of patients with the planned volume of surgical intervention: subcutaneous mastectomy using a polyester mesh endoprosthesis with a fluoropolymer coating and simultaneous prepectoral placement of textured implants.

Procedure: Subcutaneous mastectomy using a fluoropolymer-coated polyester mesh endoprosthesis with simultaneous prepectoral placement of textured implants.

Control group

OTHER

The control group will consist of patients who undergo surgical treatment for subcutaneous mastectomy, with simultaneous placement of textured breast implants with no polyester mesh endoprosthesis with a fluoropolymer coating

Procedure: Subcutaneous mastectomy with simultaneous prepectoral placement of textured implants.

Interventions

For this group of patients, the planned volume of surgical intervention is: subcutaneous mastectomy using a polyester mesh endoprosthesis with a fluoropolymer coating and one-stage prepectoral installation of textured implants.

Main group

This group of patients will undergo surgical intervention in deep subcutaneous mastectomy with simultaneous prepectoral placement of textured implants.

Control group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women with a verified breast cancer diagnosis over 18 years of age;
  • ECOG 0-1;
  • Stage: clinical T1, T2 or T3, N0-3, M0;
  • The thickness of subcutaneous adipose tissue (Pinch Test) is more than 5 mm
  • Signed informed voluntary consent.

You may not qualify if:

  • Women under 18 years of age;
  • ECOG 2-4;
  • Stage: clinical T4, M1;
  • The thickness of subcutaneous adipose tissue (Pinch Test) is less than 5 mm;
  • Intolerance and / or allergic reaction to the mesh endoprosthesis, implant and/or its component;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Petersburg State University

Saint Petersburg, Russia

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Mastectomy, Subcutaneous

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

MastectomySurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Main group- The main group will consist of patients undergoing surgical treatment for subcutaneous mastectomy using a polyester mesh endoprosthesis with a fluoropolymer coating, with simultaneous prepectoral placement of textured implants. Control group-The control group will consist of patients who undergo surgical treatment for subcutaneous mastectomy, with simultaneous placement of textured breast implants.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 2, 2025

First Posted

September 22, 2025

Study Start

May 15, 2025

Primary Completion (Estimated)

May 15, 2026

Study Completion (Estimated)

May 15, 2027

Last Updated

September 22, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations